Evidence map›Paper›PMID 34459931›Full record

ArticleArchives of toxicology2021

Safety assessment of cosmetics by read across applied to metabolomics data of in vitro skin and liver models.

Carine Jacques, Emilien L Jamin, Isabelle Jouanin, Cécile Canlet, Marie Tremblay-Franco, Jean-François Martin, Daniel Zalko, Yves Brunel, Sandrine Bessou-Touya, Laurent Debrauwer and 2 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Archives of toxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Current Knowledge in Skin Metabolomics: Updates from Literature Review.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Carine Jacques *Centre R&D Pierre Fabre, Pierre Fabre Dermo-Cosmétique, Avenue Hubert Curien, Cedex 01, 31025, Toulouse, France. carine.jacques@pierre-fabre.com.ORCID 0000-0001-6839-6417
Emilien L Jamin *Metatoul-AXIOM Platform, National Infrastructure for Metabolomics and Fluxomics: MetaboHUB, Toxalim, INRAE, 31027, Toulouse, France.
Isabelle JouaninMetatoul-AXIOM Platform, National Infrastructure for Metabolomics and Fluxomics: MetaboHUB, Toxalim, INRAE, 31027, Toulouse, France.
Cécile CanletMetatoul-AXIOM Platform, National Infrastructure for Metabolomics and Fluxomics: MetaboHUB, Toxalim, INRAE, 31027, Toulouse, France.
Marie Tremblay-FrancoMetatoul-AXIOM Platform, National Infrastructure for Metabolomics and Fluxomics: MetaboHUB, Toxalim, INRAE, 31027, Toulouse, France.
Jean-François MartinMetatoul-AXIOM Platform, National Infrastructure for Metabolomics and Fluxomics: MetaboHUB, Toxalim, INRAE, 31027, Toulouse, France.
Daniel ZalkoUMR1331 Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, 31027, Toulouse, France.
Yves BrunelCentre R&D Pierre Fabre, Pierre Fabre Dermo-Cosmétique, Avenue Hubert Curien, Cedex 01, 31025, Toulouse, France.
Sandrine Bessou-TouyaCentre R&D Pierre Fabre, Pierre Fabre Dermo-Cosmétique, Avenue Hubert Curien, Cedex 01, 31025, Toulouse, France.
Laurent DebrauwerMetatoul-AXIOM Platform, National Infrastructure for Metabolomics and Fluxomics: MetaboHUB, Toxalim, INRAE, 31027, Toulouse, France.
Pierre-Jacques FerretCentre R&D Pierre Fabre, Pierre Fabre Dermo-Cosmétique, Avenue Hubert Curien, Cedex 01, 31025, Toulouse, France.
Hélène DuplanCentre R&D Pierre Fabre, Pierre Fabre Dermo-Cosmétique, Avenue Hubert Curien, Cedex 01, 31025, Toulouse, France.
Université Toulouse III - Paul Sabatier · FRPierre Fabre (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a result of the cosmetics testing ban, safety evaluations of cosmetics ingredients must now be conducted using animal-free methods. A common approach is read across, which is mainly based on structural similarities but can also be conducted using biological endpoints. Here, metabolomics was used to assess biological effects to enable a read across between a candidate cosmetic ingredient, DIV665, only studied using in vitro assays, and a structurally similar reference compound, PA102, previously investigated using traditional in vivo toxicity methods. The (1) cutaneous distribution after topical application, (2) skin metabolism, (3) liver metabolism and (4) effect on the intracellular metabolomic profiles of in vitro skin and hepatic models, SkinEthic

Indexed as

AnimalsCell LineCells, CulturedConsumer Product SafetyCosmeticsDecanoic AcidsFemaleHumansLiverMetabolomicsSkinSwineToxicity Tests10-hydroxydecanoic acidCosmeticsDecanoic AcidsMetabolomicsRead-acrossSkin metabolismSkin model

Identifiers

PMID34459931
OpenAlexW3198081660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.